SILO
SILO
NASDAQ · Biotechnology

Silo Pharma Inc

$0.36
+0.02 (+6.22%)
As of Mar 31, 5:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
291.0K
Net Income
-17,720,136
Gross Margin
91.9%
Profit Margin
-6,092.8%
Rev Growth
+1.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 91.9% 91.9% 63.9% 63.9%
Operating Margin -6,526.6% -5,874.0% 18.2% 20.0%
Profit Margin -6,092.8% -5,788.1% 17.8% 16.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 291.0K 288.1K 653.1K 554.3K
Gross Profit 267.4K 264.8K 417.2K 354.1K
Operating Income -18,991,187 -16,924,515 118.9K 110.9K
Net Income -17,720,136 -15,791,783 116.0K 91.5K
Gross Margin 91.9% 91.9% 63.9% 63.9%
Operating Margin -6,526.6% -5,874.0% 18.2% 20.0%
Profit Margin -6,092.8% -5,788.1% 17.8% 16.5%
Rev Growth +1.0% +1.0% -9.1% -7.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 583.1K 550.9K
Total Equity 1.94M 1.85M
D/E Ratio 0.30 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,982,042 -17,856,163 172.6K 151.1K
Free Cash Flow 101.3K 71.5K